China Universal Asset Management Co., Ltd. Instil Bio, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$0.4 - $0.63 $656 - $1,033	1,641 Added 96.25%	3,346 $1,000
Q3 2023 Oct 30, 2023	BUY	$0.4 - $0.63 $656 - $1,033	1,641 Added 96.25%	3,346 $1,000
Q2 2023 May 21, 2024	SELL	$0.51 - $0.67 $27 - $35	-53 Reduced 3.01%	1,705 $0
Q2 2023 Jul 27, 2023	SELL	$0.51 - $0.67 $27 - $35	-53 Reduced 3.01%	1,705 $1,000
Q1 2023 May 21, 2024	BUY	$0.6 - $0.91 $264 - $400	440 Added 33.38%	1,758 $1,000
Q1 2023 Apr 27, 2023	BUY	$0.6 - $0.91 $264 - $400	440 Added 33.38%	1,758 $1,000
Q4 2022 May 21, 2024	BUY	$0.48 - $5.33 $632 - $7,024	1,318 New	1,318 $0
Q4 2022 Jan 31, 2023	BUY	$0.48 - $5.33 $49 - $554	104 Added 8.57%	1,318 $1,000
Q3 2022 Oct 21, 2022	BUY	$4.65 - $7.37 $5,645 - $8,947	1,214 New	1,214 $6,000

Others Institutions Holding TIL

# of Institutions

Shares Held

1.9M

Call Options Held

Put Options Held

View Full List

About Instil Bio, Inc.

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.67B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

More about TIL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account